BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Lynk Pharmaceuticals Secures China NDA Acceptance For Zemprocitinib In Atopic Dermatitis

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammat...

April 13, 2026 | News

Shanghai Ark Biopharmaceutical Advances First In Human Trial Of Long Acting Influenza Therapy AK0406

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a nove...

April 13, 2026 | News

Miracell Secures U.S. FDA Clearance For SMART M Cell System Advancing Regenerative Therapies

Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability Miracell, a...

April 13, 2026 | News

Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with Precision Health Research, S...

April 10, 2026 | News

Biocon Limited Launches Bosaya And Aukelso In The United States To Expand Bone Health Access

Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with ...

April 10, 2026 | News

Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal

Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate considera...

April 09, 2026 | News

ATLATL And Daiichi Sankyo Partner To Advance APAC Driven Biopharma Innovation

ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreem...

April 09, 2026 | News

IDEAYA Biosciences Advances IDE574 Into Phase 1 As First Patient Enrolled For KAT6 And KAT7 Dual Inhibitor

Potential first-in-class and selective equipotent dual inhibitor of KAT6/7 with single-digit to low teens nano-molar cellular potency...

April 07, 2026 | News

Neurocrine Biosciences To Acquire Soleno Therapeutics For $2.9 Billion To Strengthen Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and...

April 07, 2026 | News

Alphamab Oncology Reports Phase III Success For Anbenitamab In HER2 Positive Breast Cancer

Alphamab Oncology announced that HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed wit...

April 06, 2026 | News

Syneron Bio Secures Series B Financing To Advance Macrocyclic Peptide Discovery Platform And Clinical Pipeline

Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on Marc...

April 06, 2026 | News

From Staging to Survival: How AI-Driven Histological Analysis Is Solving Colorectal Cancer's Overtreatment Problem

The hidden cost of getting treatment decisions wrong Colorectal cancer (CRC) is one of the most prevalent and lethal cancers worldwide, ranking among the ...

April 02, 2026 | Expert Insight | By Dr. Torbjørn Furuseth, CEO and Co-Founder, DoMore Diagnostics

Roche Secures FDA Clearance For Cobas c 703 And Cobas ISE Neo Analytical Units

The cobas® c 703 and cobas® ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory work...

April 01, 2026 | News

Bio Sourcing And Tiny Cargo Partner To Develop Oral Monoclonal Antibody Therapies Using Milk Derived Exosomes

Bio‑Sourcing SA (‘Bio-Sourcing’) and The Tiny Cargo Company (‘Tiny Cargo’) today announce a strategic collaboration to co‑devel...

March 31, 2026 | News

Stay Connected